Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-2570 Phase 2 in Moderate-to-Severe Plaque Psoriasis
CTR20233893Phase 2Completed
- Sponsor
- Eucure Biopharma
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of D-2570 in plaque psoriasis, sponsored by Eucure Biopharma. Started Dec 2023; status: completed.
02
Drugs
D-2570
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20233893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233893.